TNF and rheumatoid arthritis: The most distinguished research in the field of precision medicine for rheumatoid arthritis is exemplified by the R4RA (rituximab vs. tocilizumab in anti‐TNF inadequate responder patients with rheumatoid arthritis) study, a clinical trial underpinned by synovial biopsy [31, 32].